Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 5, 1999, Pages 413-419

  Gammon, Marilie D ^a   Hibshoosh, Hanina ^b   Terry, Mary Beth ^a   Bose, Shikha ^b   Schoenberg, Janet B ^c   Brinton, Louise A ^d   Bernstein, Jonine L ^e   Thompson, W Douglas ^f  

^a Division of Epidemiology ^*  (United States)

^b Department of Pathology ^*  (United States)

^c Applied Cancer Epidemiology Program   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTHERN MAINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; HUMAN; IMMUNOHISTOCHEMISTRY; ONCOGENE NEU; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AMERICAS; BIOLOGY; BREAST CANCER; CANCER; CASE CONTROL STUDIES; CONTRACEPTION; CONTRACEPTIVE METHODS; DEVELOPED COUNTRIES; DISEASES; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; INCIDENCE; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; MEASUREMENT; NEOPLASMS; NEW JERSEY; NORTH AMERICA; NORTHERN AMERICA; ORAL CONTRACEPTIVES; RESEARCH METHODOLOGY; RESEARCH REPORT; RISK FACTORS; STUDIES; UNITED STATES;

ADULT; AGE DISTRIBUTION; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INCIDENCE; LOGISTIC MODELS; NEOPLASMS, HORMONE-DEPENDENT; NEW JERSEY; ODDS RATIO; RECEPTOR, ERBB-2; RISK FACTORS;

EID: 0032944483     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiologic studies. Lancet, 347: 1713-1727, 1996.
2. Malone, K. E., Daling, J. R., and Weiss, N. S. Oral contraceptives and breast cancer risk. Epidemiol. Rev., 15: 80-97, 1993.
3. Brinton, L. A., Daling, J. R., Liff, J., Schoenberg, J. B., Malone, K. E., Stanford, J. L., Coates, R. J., Gammon, M. D., Hanson, L. H. R. Oral contraceptives and breast cancer risk among younger women. J. Natl. Cancer Inst., 87: 827-835, 1995.
4. Habel, L. A., and Stanford, J. L. Hormone receptors and breast cancer. Epidemiol. Rev., 15: 209-219, 1993.
5. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., and Ullrich, A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
6. Allred, D. C., Clark, G. M., and Molina, R. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum. Pathol., 23: 974-979, 1992.
7. Taylor, J. A., Sandler, D. P., Bloomfield, C. D., Shore, D. L., Ball, E. D., Neubauer, A., McIntyre, O. R., and Liu, E. ras oncogene activation and occupational exposures in acute myeloid leukemia. J. Natl. Cancer Inst., 84: 1626-1632, 1992.
8. Olsson, H., Borg, A., Gerno, M., Ranstam, J., and Sigurdsson. H. HER-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones. J. Natl. Cancer Inst., 83: 1483-1487, 1991.
9. Treurniet, H. F., Rookus, M. A., Peterse, J. L., Hart, A. A. M., and van Leeuwen, F. E. Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor. Cancer Res., 52: 2344-2345, 1992.
10. Waksberg, J. Sampling methods for random digit dialing. J. Am. Statistical Assoc., 73: 40-46, 1978.
11. Gammon, M. D., Hibshoosh, H., Terry, M. B., Bose, S., Schoenberg, J. B., Brinton, L. A., Bernstein, J. L., and Thompson, W. D. Cigarette smoking and other risk factors in relation to p53 protein expression in breast cancer among young women. Cancer Epidemiol. Biomark. Prev., 8: 255-263, 1999.
12. Bacus, S. S., Ruby, S. G., Weinberg, D. S., Chin, D., Ortiz, R., and Bacus, J. W. HER-2/neu oncogene expression and proliferation in breast cancers. Am. J. Pathol., 137: 103-111, 1990.
13. Czerniak, B. Quantitation of oncogene products by computer-assisted image analysis and flow cytometry. J. Histol. Cytol., 38: 463-466, 1990.
14. Hosmer, D.W., and Lemenshow, S. Applied Logistic Regression. New York: John Wiley & Sons, 1989.
15. Kelsey, J. L., Whittemore, A. S., Evans, A. S., and Thompson, W. D. Methods in Observational Epidemiology, Ed. 2, pp. 142-146. New York: Oxford University Press, 1996.
16. Gammon, M. D., Schoenberg, J. B., Teitelbaum, S. L., Brinton, L. A., Potischman, N., Swanson, C. A., Brogan, D. J., Coates, R. J., Malone, K. E., and Stanford, J. L. Cigarette smoking and breast cancer risk among young women. Cancer Causes Control, 9: 583-590, 1998.
17. Ciocca, D. R., Fujimura, F. K., Tandon, A. K., Clark, G. M., Mark, C., Lee-Chen, G. J., Pouns, G. W., Vendely, P., Owens, M. A., and Pandian, M. R. Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers. J Natl. Cancer Inst., 84: 1279-1282, 1992.
18. Nakopoulou, L. L., Alexiadou, A., Theodoropoulos, G. E., Lazaris, A. C., Tzonou, A., and Keramopoulos, A. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer. J. Pathol., 179: 31-38, 1996.
19. Rosen, P. P., Lesser, M. L., Arroyo, C. D., Cranor, M., Borgen, P., and Norton, L. Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. Cancer (Phila.), 75: 1320-1326, 1995.
20. Venter, D. J., Tuzi, N. L., Kumar, S., and Gullick, W. J. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistochemical assessment correlates with gene amplification. Lancet, 2: 69-72, 1987.
21. De Potter, C. R. The neu oncogene: more than a prognostic indicator. Hum. Pathol., 25: 1264-1268, 1994.
22. Rudas, M., Neumayer, R., Gnant, M. F. X., Mittelbock, M., Jakesz, R., and Reiner, A. p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Eur. J. Cancer, 33: 39-44, 1997.
23. Olsson, H. Reproductive events, occurring in adolescence at the time of development of reproductive organs and at the time of tumour initiation, have a bearing on growth characteristics and reproductive hormone regulation in normal and tumour tissue investigated decades later-a hypothesis. Med. Hypotheses, 28: 93-97, 1989.
24. de Bortoli, M., Maggiora, P., Capello, D., Antoniotti, S., Saviozzi, S., Sapei, M. L., and Dati, C. Hormonal control of growth factor receptor expression. Ann. N. Y. Acad. Sci., 784: 336-348, 1996.